You are here

  • Home
  • Archive
  • Volume 64, Issue Suppl 1
  • PTU-085 Clinical benefits of the use of infliximab (INF) and adalumimab (ADA) therapeutic drug level monitoring in a uk district general hospital

Article metrics

Article menu
Download PDFPDF
Inflammatory Bowel Disease I
PTU-085 Clinical benefits of the use of infliximab (INF) and adalumimab (ADA) therapeutic drug level monitoring in a uk district general hospital

 

Online download statistics by month:

Online download statistics by month: June 2015 to March 2024

AbstractFullPdf
Jun 2015300
Jul 20151103
Aug 20151201
Sep 20152003
Oct 2015300
Nov 20151100
Dec 2015801
Jan 2016500
Feb 2016600
Mar 2016802
Apr 2016400
May 2016500
Jun 2016701
Jul 2016200
Aug 2016501
Sep 2016601
Oct 2016400
Nov 2016500
Dec 2016702
Jan 2017100
Feb 2017400
Mar 2017201
Apr 2017400
May 2017200
Jun 2017100
Jul 2017401
Aug 2017801
Sep 2017401
Oct 2017800
Nov 20172400
Dec 20171000
Jan 2018600
Feb 2018200
Mar 20183601
Apr 2018400
May 20182600
Jun 2018600
Jul 2018800
Aug 2018800
Sep 2018800
Oct 2018800
Nov 20182001
Dec 20183201
Jan 20191200
Feb 20191400
Mar 20191600
Apr 20191500
May 2019600
Jun 2019600
Jul 2019800
Aug 2019600
Sep 2019200
Oct 2019200
Nov 2019601
Dec 2019800
Jan 2020200
Feb 2020402
Mar 2020400
Apr 20201400
May 20202300
Jun 2020200
Jul 2020800
Aug 20201000
Sep 20204801
Oct 20201200
Nov 20201500
Dec 20201402
Jan 2021200
Feb 2021200
Mar 2021201
Apr 2021400
Aug 2021200
Oct 20211200
Nov 20211800
Dec 2021400
Jan 20221401
Feb 2022800
Apr 2022600
May 2022800
Jun 20222000
Jul 20221001
Aug 2022800
Sep 20221000
Oct 20222200
Nov 20222000
Dec 2022800
Jan 2023400
Feb 2023200
Mar 2023400
Apr 2023600
May 2023900
Jul 2023200
Aug 2023300
Sep 2023600
Oct 2023200
Nov 2023400
Dec 20231000
Jan 2024400
Feb 20241000
Mar 2024200
Total873031